SCHEMBL11097640

SCHEMBL11097640

O=C1CCC(C(=O)O)(c2ccc(Br)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C1 Q04828 2/20 0.47
HSD11B1 P28845 1/20 0.41
KMT2A Q03164 5/20 0.40
MEN1 O00255 2/20 0.40
CYP2C9 P11712 2/20 0.40
TSHR P16473 1/20 0.39
HDAC1 Q13547 3/20 0.38
TET3 O43151 2/20 0.37
FBXL19 Q6PCT2 2/20 0.37
CXXC5 Q7LFL8 2/20 0.37
KDM2B Q8NHM5 2/20 0.37
CXXC4 Q9H2H0 2/20 0.37
KDM2A Q9Y2K7 2/20 0.37
APP P05067 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 1/20 0.37
TET1 Q8NFU7 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butylamine SCHEMBL15352312 0.91 AKR1C1 (0.40) AKR1C1HSD11B1KMT2AMEN1CYP2C9
SCHEMBL2221 0.87 AKR1C1 (0.55) AKR1C1KMT2AMEN1CYP2C9TSHR
SCHEMBL3910628 0.85 AKR1C1 (0.53) AKR1C1KMT2AMEN1CYP2C9TSHR
SCHEMBL19358562 0.84 HSD11B1 (0.40) HSD11B1KMT2AMEN1CYP2C9HDAC1
SCHEMBL631791 0.83 AKR1C1 (0.68) AKR1C1HSD11B1KMT2AMEN1CYP2C9
SCHEMBL9966557 0.83 AKR1C1 (0.68) AKR1C1HSD11B1KMT2AMEN1TSHR
Water SCHEMBL3910626 0.83 AKR1C1 (0.52) AKR1C1KMT2AMEN1CYP2C9TSHR
SCHEMBL1492737 0.83 AKR1C1 (0.62) AKR1C1HSD11B1KMT2AMEN1CYP2C9
SCHEMBL11075416 0.82 KMT2A (0.54) AKR1C1HSD11B1KMT2AMEN1CYP2C9
SCHEMBL5768239 0.82 CYP2C9 (0.50) AKR1C1HSD11B1KMT2AMEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2852590-B1 CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS NOVARTIS AG (CH) 2017-02-01 EP disclosed
EP-2852590-B1 CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS NOVARTIS AG (CH) 2017-02-01 EP disclosed
EP-2852590-A1 CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS Novartis AG (CH) 2015-04-01 EP disclosed
WO-2013160873-A1 CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS NOVARTIS AG (CH) 2013-10-31 WO disclosed
WO-2013160873-A1 CYCLIC BRIDGEHEAD ETHER DGAT1 INHIBITORS NOVARTIS AG (CH) 2013-10-31 WO disclosed
US-4460604-A ANALGESICS, NARCOTIC ANTAGONIST THE UPJOHN COMPANY (US) 1984-07-17 US disclosed
US-4180584-A ANALGESIC; NARCOTIC ANTAGONIST THE UPJOHN COMPANY (US) 1979-12-25 US disclosed
US-4065573-A ANALGESICS THE UPJOHN COMPANY (US) 1977-12-27 US disclosed